Japan, March 24 -- GENZYME CORP has got intellectual property rights for 'AAV VECTORS FOR RETINAL AND CNS GENE THERAPY.' Other related details are as follows:
Application Number: JP,2024-231483
Category (FI): A61K35/76,A61K48/00,A61P25/00,A61P25/28,A61P27/02,A61P43/00,105,C12N15/113@Z,C12N15/864,100@Z,C12N7/01
Stage: Grant (IP right document published.)
Filing Date: Dec. 27, 2024
Publication Date: April 17, 2025
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication....